CAMPOCHIARO, CORRADO
 Distribuzione geografica
Continente #
NA - Nord America 1.691
AS - Asia 1.216
EU - Europa 1.096
SA - Sud America 234
AF - Africa 21
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.259
Nazione #
US - Stati Uniti d'America 1.629
SG - Singapore 518
RO - Romania 435
CN - Cina 377
IT - Italia 218
BR - Brasile 191
HK - Hong Kong 141
DE - Germania 108
VN - Vietnam 72
SE - Svezia 55
GB - Regno Unito 48
CA - Canada 40
FI - Finlandia 40
RU - Federazione Russa 34
FR - Francia 33
AT - Austria 26
IN - India 26
NL - Olanda 21
PL - Polonia 21
ES - Italia 19
JP - Giappone 19
MX - Messico 18
AR - Argentina 17
ZA - Sudafrica 13
BD - Bangladesh 12
LT - Lituania 12
KR - Corea 8
EC - Ecuador 7
PY - Paraguay 7
TR - Turchia 7
UZ - Uzbekistan 7
ID - Indonesia 6
NO - Norvegia 6
AE - Emirati Arabi Uniti 5
LU - Lussemburgo 5
PK - Pakistan 5
CL - Cile 4
VE - Venezuela 4
CO - Colombia 3
IE - Irlanda 3
IQ - Iraq 3
PT - Portogallo 3
TN - Tunisia 3
UA - Ucraina 3
DO - Repubblica Dominicana 2
EG - Egitto 2
KE - Kenya 2
KZ - Kazakistan 2
LV - Lettonia 2
TW - Taiwan 2
AM - Armenia 1
AZ - Azerbaigian 1
BE - Belgio 1
BG - Bulgaria 1
BH - Bahrain 1
CR - Costa Rica 1
EU - Europa 1
HR - Croazia 1
IL - Israele 1
IR - Iran 1
MA - Marocco 1
MD - Moldavia 1
SA - Arabia Saudita 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 4.259
Città #
Dallas 927
Singapore 283
Hong Kong 136
Ashburn 134
Beijing 85
Shanghai 78
Hefei 58
Los Angeles 58
Milan 58
New York 53
Munich 39
Boardman 36
Nuremberg 31
Ho Chi Minh City 27
Denver 21
Brooklyn 17
São Paulo 17
Tokyo 17
Montreal 16
Poplar 16
Warsaw 16
Helsinki 15
Santa Clara 14
Amsterdam 13
Moscow 13
Phoenix 13
Rome 13
Turku 13
Falkenstein 12
Guangzhou 12
Johannesburg 12
Lappeenranta 12
Chennai 11
Stockholm 11
Atlanta 10
Chicago 10
Frankfurt am Main 10
Houston 9
Rio de Janeiro 9
Toronto 9
Hanoi 8
Lawrence 8
London 8
Naples 8
Princeton 8
Seongnam-si 8
Vaprio d'Adda 8
Vienna 8
Ankara 7
Boston 7
Buffalo 7
Cesano Boscone 7
Mugnano di Napoli 7
Secaucus 7
Tashkent 7
Xi'an 7
Bergamo 6
Oslo 6
Querétaro 6
St Louis 6
Ancona 5
Cagliari 5
City of London 5
Esch-sur-Alzette 5
Kassel 5
Mexico City 5
Orem 5
Shenzhen 5
Belo Horizonte 4
Haiphong 4
Quito 4
Romagnano Sesia 4
Roubaix 4
San Jose 4
Segrate 4
The Dalles 4
Turin 4
Alessandria 3
Amadora 3
Angera 3
Annapolis 3
Asunción 3
Augusta 3
Bexley 3
Brasília 3
Brescia 3
Campos dos Goytacazes 3
Charleston 3
Da Nang 3
Fortaleza 3
Hangzhou 3
Hải Dương 3
Mumbai 3
New Delhi 3
Oklahoma City 3
Osimo 3
Ottawa 3
Porto Alegre 3
Pune 3
Recife 3
Totale 2.633
Nome #
Digital Ulcers and Ventricular Arrhythmias as Red Flags to Predict Replacement Myocardial Fibrosis in Systemic Sclerosis 417
Intercalated Disc Abnormalities Are Linked to Arrhythmias in Inflammatory Cardiomyopathy 380
Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study 319
Monkeypox in a patient with undifferentiated connective tissue disease 215
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 131
Myocarditis in anti-synthetase syndrome: clinical features and diagnostic modalities 94
Liquid biopsy of cerebrospinal fluid enabling the detection and therapeutic targeting of the BRAFV600E mutation in a patient with overlapping Erdheim-Chester/Rosai-Dorfman disease 82
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease 80
Does the impact of COVID-19 on patients with systemic sclerosis change over time? 78
Cardiac magnetic resonance findings in acute and post-acute COVID-19 patients with suspected myocarditis 76
Distinctive clinical traits of lupus-related myocarditis: a multicentre retrospective study 76
Clinical profiling and outcomes of viral myocarditis manifesting with ventricular arrhythmias 73
Adherence to the Mediterranean Diet in Italian Patients With Systemic Sclerosis: An Epidemiologic Survey 71
Clinical Applications of FDG-PET Scan in Arrhythmic Myocarditis 70
La misurazione quantitativa dell’uptake di 18F-FDG in TC/PET riflette l’espansione dei plasmablasti circolanti nella malattia IgG4 correlata 70
CD4+ Memory Stem T Cells Recognizing Citrullinated Epitopes Are Expanded in Patients With Rheumatoid Arthritis and Sensitive to Tumor Necrosis Factor Blockade 68
Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: an observational prospective open-label cohort study 66
Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation 65
Cardiovascular involvement in Erdheim-Chester diseases is associated with myocardial fibrosis and atrial dysfunction 65
Myelomonocytic cells in giant cell arteritis activate trained immunity programs sustaining inflammation and cytokine production 64
Canakinumab as first-line biological therapy in Still’s disease and differences between the systemic and the chronic-articular courses: Real-life experience from the international AIDA registry 64
Interstitial lung disease in limited cutaneous systemic sclerosis patients: never let your guard down 63
Extracellular vesicles and interstitial lung disease in systemic sclerosis: State of the art! 63
Efficacy and safety of apremilast for Behçet's syndrome: a real-life single-centre Italian experience 63
Case report: Cytopenias in VEXAS syndrome - a WHO 2022 based approach in a single-center cohort 61
Calcinosis in systemic sclerosis: An update on pathogenesis, related complications, and management: A heavy burden still waiting to be lifted off patients’ hands 61
Anakinra for the Treatment of Antisynthetase Syndrome: A Monocentric Case Series and a Systematic Literature Review 61
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase 61
A multi-national survey to identify clinicians’ perspectives concerning Proton Pump inhibitors in patients with systemic sclerosis 60
A Multinational Survey Investigating the Unmet Needs and Patient Perspectives Concerning Proton Pump Inhibitors in Systemic Sclerosis 60
Case report: Successful use of mepolizumab for immune checkpoint inhibitors–induced hypereosinophilic syndrome in two patients with solid malignancies 60
Multimodal Detection and Targeting of Biopsy-Proven Myocardial Inflammation in Genetic Cardiomyopathies: A Pilot Report 57
Drug development and novel therapeutics to ensure a personalized approach in the treatment of systemic sclerosis 57
Systemic sclerosis Progression INvestiGation (SPRING) Italian registry: demographic and clinico-serological features of scleroderma spectrum 57
Effectiveness of a two-year tapered course of tocilizumab in patients with giant cell arteritis: A single-centre prospective study 56
VEXAS associated acute disseminated Encephalo-Myelitis (ADEM)-like syndrome: A case report and review of the literature 52
High-dose anakinra in addition to standard of care including corticosteroids in patients with severe COVID-19 treated with non-invasive ventilation 52
Rituximab retention rate in systemic sclerosis: a long term real-life multicentre study 51
Cardiac involvement, a threatening very early manifestation of systemic sclerosis: evidence from VEDOSS patients 51
Systemic sclerosis myocarditis has unique clinical, histological and prognostic features: a comparative histological analysis 51
Inflammatory rheumatic diseases with onset after SARS-CoV-2 infection or COVID-19 vaccination: a report of 267 cases from the COVID-19 and ASD group 49
Giant cell arteritis: Update on clinical manifestations, diagnosis, and management 49
Ventricular Arrhythmias in Myocarditis: Characterization and Relationships With Myocardial Inflammation 49
HETEROGENEITY OF CYTOPENIAS IN VEXAS SYNDROME: A SINGLE CENTRE EXPERIENCE 46
Beyond very early systemic sclerosis: deciphering pre‑scleroderma and its trajectories to open new avenues for preventive medicine 41
Towards a comprehensive approach to the management and prognosis of systemic sclerosis's patients: The role of comorbidities in the SPRING-SIR registry 41
Effectiveness and safety of mycophenolate mofetil and rituximab combination therapy for immune idiopathic myopathies 41
Corrigendum to “Intravenous immunoglobulins reduce skin thickness in systemic sclerosis: evidence from Systematic Literature Review and from real life experience” [Autoimmunity Reviews, Volume 20, Issue 12, December 2021, 102981](S1568997221002615)(10.1016/j.autrev.2021.102981) 38
Cardiac Sarcoidosis: Clinical Insights, Diagnosis, and Management Strategies 35
Mechanisms of hematopoietic clonal dominance in VEXAS syndrome 35
Surgical management of digital ulcers in systemic sclerosis: A systematic literature review 33
Successful use of ixekizumab for glucocorticoid-free remission maintenance in giant cell arteritis 33
Open questions on the management of targeted therapies for the treatment of systemic sclerosis-interstitial lung disease: results of a EUSTAR survey based on a systemic literature review 32
Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society for Rheumatology 30
Sex influence on outcomes of patients with systemic sclerosis-associated interstitial lung disease: a EUSTAR database analysis 29
Non-surgical local treatments of digital ulcers in systemic sclerosis: a systematic literature review 28
Unraveling the Pathogenesis of Calcinosis in Systemic Sclerosis: A Molecular and Clinical Insight 27
Systemic pharmacological treatment of digital ulcers in systemic sclerosis: a systematic literature review 27
Doppler ultrasound, a noninvasive tool for the study of mesenteric arterial flow in systemic sclerosis: a cross-sectional study of a patient cohort with review and meta-analysis of the literature 26
Practice pattern for the use of intravenous iloprost for the treatment of peripheral vasculopathy in systemic sclerosis: A case–control study from the Italian national multicenter “SPRING” (Systemic Sclerosis Progression InvestiGation) Registry 25
Is cyclophosphamide still the gold standard in early severe rapidly progressive systemic sclerosis? 25
Doppler ultrasound unveils splanchnic arteries ischemia allowing early successful revascularization in symptomatic systemic sclerosis patients 4
Recombinant human hyaluronidase-facilitated subcutaneous immunoglobulin (hf-SCIg) for inflammatory myositis: a multicenter retrospective real-world observational study 2
Totale 4.466
Categoria #
all - tutte 17.796
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.796


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216 0 0 0 0 0 2 0 0 1 0 2 1
2021/202231 0 0 3 3 1 8 2 2 5 3 2 2
2022/2023109 19 16 9 0 0 13 28 14 4 0 5 1
2023/2024314 4 13 15 30 25 48 38 38 3 18 28 54
2024/20251.457 55 14 39 62 54 89 585 114 132 90 90 133
2025/20262.543 304 608 673 539 392 27 0 0 0 0 0 0
Totale 4.466